Epidemiology

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Jose L Pablos, María Galindo, Loreto Carmona, Ana Lledó, Miriam Retuerto, Ricardo Blanco, Miguel A Gonzalez-Gay, David Martinez-Lopez, Isabel Castrejón, José M Alvaro-Gracia, David Fernández Fernández, Antonio Mera-Varela, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Fernandez-Nebro, RIER investigators group, Rodrigo Aguirre, Álvaro Seijas-López, Francisco J Blanco, Patricia Carreira, María Martín-López, Antonio Gonzalez, Amaya Puig-Kröger, Luis Salas

10.1136/annrheumdis-2020-218296

August 12, 2020

Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Dalifer D Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose I Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo

10.1136/annrheumdis-2020-217984

August 7, 2020

Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome

Mirko Scarsi, Silvia Piantoni, Enrico Colombo, Paolo Airó, Donata Richini, Marco Miclini, Valeria Bertasi, Marta Bianchi, Damiano Bottone, Patrizia Civelli, Maria-Sofia Cotelli, Ezio Damiolini, Gloria Galbassini, Diego Gatta, Maria-Laura Ghirardelli, Roberto Magri, Paola Malamani, Monia Mendeni, Stefano Molinari, Andrea Morotti, Luisa Salada, Marinella Turla, Angiola Vender, Angela Tincani, Antonio Brucato, Franco Franceschini, Roberto Furloni, Laura Andreoli

10.1136/annrheumdis-2020-217712

July 30, 2020

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences

Piero Ruscitti, Federico Bruno, Onorina Berardicurti, Chiara Acanfora, Viktoriya Pavlych, Pierpaolo Palumbo, Alessandro Conforti, Francesco Carubbi, Ilenia Di Cola, Paola Di Benedetto, Paola Cipriani, Davide Grassi, Carlo Masciocchi, Annamaria Iagnocco, Antonio Barile, Roberto Giacomelli

10.1136/annrheumdis-2020-218048

July 21, 2020

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Sofia Ramiro, Rémy L M Mostard, César Magro-Checa, Christel M P van Dongen, Tom Dormans, Jacqueline Buijs, Michiel Gronenschild, Martijn D de Kruif, Eric H J van Haren, Tom van Kraaij, Mathie P G Leers, Ralph Peeters, Dennis R Wong, Robert B M Landewé

10.1136/annrheumdis-2020-218479

July 20, 2020

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Angela Napolitano, Salvatore La Marca, Nicola Boffini, Valentina Da Prat, Gaetano Di Terlizzi, Marco Lanzillotta, Patrizia Rovere Querini, Annalisa Ruggeri, Giovanni Landoni, Moreno Tresoldi, Fabio Ciceri, ALberto Zangrillo, Francesco De Cobelli, Lorenzo Dagna, SARI-RAF Study Group members, Piera Angelillo, Andrea Assanelli, Elena Baldissera, Nicola Boffini, Enrica Paola Bozzolo, Stefania Calvisi, Corrado Campochiaro, Valentina Da Prat, Diana Canetti, Adriana Cariddi, Antonella Castagna, Giulio Cavalli, Maria Pia Cicalese, Fabio Ciceri, Lorenzo Dagna, Francesco De Cobelli, Giacomo De Luca, Emanuel Della-Torre, Giuseppe Di Lucca, Gaetano di Terlizzi, Nicola Farina, Maria Fazio, Salvatore La Marca, Giovanni Landoni, Marco Lanzillotta, Gaia Mancuso, Giacomo Monti, Luca Moroni, Angela Napolitano, Chiara Oltolini, Diego Palumbo, Marco Ripa, Patrizia Rovere-Querini, Annalisa Ruggeri, Silvia Sartorelli, Paolo Scarpellini, Marzia Spessot, Alessandro Tomelleri, Moreno Tresoldi, Alberto Zangrillo

10.1136/annrheumdis-2020-218122

July 3, 2020

Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group

Sabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, Beverley J Shea, George A Wells, Vivian Andrea Welch, Daniel E Furst, Maarten de Wit, Marieke Voshaar, Carsten Bogh Juhl, Maarten Boers, Reuben Escorpizo, Thasia G Woodworth, Annelies Boonen, Henning Bliddal, Lyn M March, Peter Tugwell, Robin Christensen

10.1136/annrheumdis-2020-217237

June 30, 2020

Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study

Yao Huang, Zhe Chen, Yu Wang, Liang Han, Kai Qin, Wenya Huang, Ying Huang, Hui Wang, Pan Shen, Xin Ba, Weiji Lin, Hui Dong, Mingmin Zhang, Shenghao Tu

10.1136/annrheumdis-2020-217425

June 16, 2020

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

Jose L Pablos, Lydia Abasolo, Jose M Alvaro-Gracia, Francisco J Blanco, Ricardo Blanco, Isabel Castrejón, David Fernandez-Fernandez, Benjamín Fernandez-Gutierrez, María Galindo-Izquierdo, Miguel A Gonzalez-Gay, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Mera Varela, Miriam Retuerto, Alvaro Seijas-Lopez

10.1136/annrheumdis-2020-217763

June 12, 2020

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I Danila, Laure Gossec, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Saskia Lawson-Tovey, Elsa F Mateus, Stephanie Rush, Gabriela Schmajuk, Julia Simard, Anja Strangfeld, Laura Trupin, Katherine D Wysham, Suleman Bhana, Wendy Costello, Rebecca Grainger, Jonathan S Hausmann, Jean W Liew, Emily Sirotich, Paul Sufka, Zachary S Wallace, Jinoos Yazdany, Pedro M Machado, Philip C Robinson

10.1136/annrheumdis-2020-217871

May 29, 2020